BRZE · sample dossier
Braze, Inc. Class A Common Stock
55/100
OutdatedGenerated Sep 5, 2026 · 10:00 AM UTC · 62 days ago
This copy is frozen (Sep 5). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierBRZE
EquityBraze, Inc. Class A Common Stock · XNAS
Decision context
Recommendation
Balanced between solid Momentum (86/100) and constrained Valuation (34/100).
A mixed picture — no strong reason to buy or sell right now.
AlphaDog Fair Value
Executive thesis & key metrics
Executive Investment Thesis
Braze, Inc. is a customer engagement platform with a market cap of $3.60B, generating 30.2% YoY revenue growth and gross margins of 66.5%. Operational expansion is supported by positive free cash flow of $1.66 per share and a low Debt/Equity ratio of 0.14, despite negative profitability marked by an EV/EBITDA of -30.50 and a net margin of -15.5%. The primary risk to the investment thesis is persistent unprofitability, underscored by a negative ROA of -7.6% and annual shareholder dilution of 6.0% YoY.
Key Metrics to Watch
What changed recently
No material changes found in the last 30 days.
Why this rating
Score 55 · Hold
Data through
OutdatedApr 30, 2026
Momentum 86/100 — 1Y return 16%.
Re-evaluate if
- Net margin falls below -12.4% (was -15.5%)
Trim / reconsider if
- ROA falls below -4.9% (was -7.6%)
- Net Margin falls below -15.5%
- Debt/Equity rises above 0.14.
Think of these dollars as a map of our value estimate for Hold — helpful context, not a reason to override the view.
A Calmer Look · Devil's Advocate
The consensus 'Hold' verdict severely understates downside risk following Braze's 58.7% six-month surge, mistaking stock-based compensation-fueled cash flow for genuine structural profitability.
May be overlooked
Consensus views $1.66 TTM free cash flow per share as proof of self-funding without reconciling it against 6.0% YoY share count dilution driven by excessive stock compensation.
The valuation multiple relies on stale Q1 financial disclosures from April 2026 (older than 90 days), leaving investors exposed to unmonitored deceleration below the reported 30.2% revenue growth rate.
The market fixates on the safe Altman Z-score of 5.59 while ignoring a weak Piotroski F-Score of 4/9 that indicates stagnant or weakening operational efficiency.
Expectations look stretched
Chasing momentum after a 58.7% 6-month and 24.3% 1-month run-up when traditional earnings multiples sit at EV/EBITDA of -30.50 and P/E of -28.5.
Assuming operating leverage will naturally emerge from 66.5% gross margins despite an ROA of -7.6% and a GAAP net loss margin of -15.5%.
Dismissing the signal sent by insiders who offloaded -$3.35M across 11 separate sell orders with zero purchases in the past 90 days.
Gross Margin falls below 66.5%.
Gross Margin falls below 66.5%.
Market context
Snapshot returns at report publication
1 month
+24.3%
3 months
+39.5%
6 months
+58.7%
1 year
+15.5%
At a Glance
A mid-sized company is riding a strong uptrend at unprofitable earnings.
Top Holders
Financial trajectory
Financial Performance
Go deeper
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
Run the next one yourself.
You just read a full BRZE dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.